September 14, 2025: Finding the Zen in Managing Atopic Dermatitis

RACE Program #:

1315782

RACE-Approved CE

1 Hour

Cost

Thanks to sponsorship from Elanco, this webinar is FREE to all!

Is JAK inhibition in your toolbox?

In this complimentary, 1-hour VETgirl-Elanco webinar, Dr. Joya Griffin, DVM, DACVD will take a dive into the world of Janus kinase inhibitors (JAK-inhibitors). Tune in as Dr. Griffin reviews what you need to know about JAK inhibitors, from their mechanism of action to utilization during diagnostic trials. Walk away knowing what cases would benefit from their use and best management practices for atopic dermatitis!

INDICATIONS 

Zenrelia (ilunocitinib tablets) is indicated for control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.

IMPORTANT SAFETY INFORMATION

Read the entire package insert before using this drug, including the Boxed Warning.

For Full prescribing information call 1 888 545 5973 or visit www.elancolabels.com/us/zenrelia.

WARNING: VACCINE-INDUCED DISEASE AND INADEQUATE IMMUNE RESPONSE TO VACCINES. Based on results of the vaccine response study, dogs receiving Zenrelia are at risk of fatal vaccine-induced disease from modified live virus vaccines and inadequate immune response to any vaccine. Discontinue Zenrelia for at least 28 days to 3 months prior to vaccination and withhold Zenrelia for at least 28 days after vaccination. Dogs should be up to date on vaccinations prior to starting Zenrelia. Do not use in dogs less than 12 months old or dogs with a serious infection. Monitor dogs for infections because Zenrelia may increase susceptibility to opportunistic infections. Neoplastic conditions (benign and malignant) were observed during clinical studies. Consider the risks and benefits of treatment in dogs with a history of recurrence of these conditions. The most common adverse reactions were vomiting, diarrhea and lethargy. Zenrelia has not been evaluated in breeding, pregnant, or lactating dogs and concurrent use with glucocorticoids, cyclosporine, or other systemic immunosuppressive agents has not been tested. For full prescribing information see package insert.

Zenrelia, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. © 2025 Elanco or its affiliates.PM-US-25-1611

Thanks to sponsorship from Elanco, the recording of this webinar will be available to view free and On-Demand HERE until December 14, 2025.

Have Questions about VETgirl Webinars?

Live Webinar FAQ

How do I get my webinar CE credit?

Not a VETgirl ELITE member? Get your learning on with the #1 veterinary CE resource – clinically relevant, practical, and accessible 24/7 on your own time! Don’t miss out – click HERE to check out your options, including our new  14-day, no-commitment ELITE Trial.

This program has been approved for continuing education credit in jurisdictions which recognize AAVSB RACE approval; however, participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education.

This webinar is for individual viewing only; VETgirl webinars are not designed nor meant to be viewed in a group setting due to RACE-CE audit purposes. Inappropriate sharing or viewing of the webinar may result in revoking of membership.

The official version of the content is in the original language. Translations are not guaranteed to be exact or accurate. Some content, such as images, videos, and PDFs, may not translate accurately. Discrepancies in translations are not binding and have no legal effect. The user assumes the risk of any inaccuracies or errors in the translation.

Only VETgirl members can leave comments. Sign In or Join VETgirl now!